Patients undergoing non cardiac surgery requiring general anesthesia based on their condition (with an estimated surgery duration of less than 4 hours)
Conditions
Interventions
The experimental group used the Yifei Huatong anesthesia depth monitoring drug delivery system for closed-loop automatic drug delivery:Closed loop automatic administration through the Yifei Huatong an
The control group received medication through traditional manual infusion method:Traditional manual infusion method for drug administration
Sponsors
Beijing Chao-Yang Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing non cardiac surgery requiring general anesthesia based on their condition (with an estimated surgery duration of less than 4 hours); 2. 18 <= Age <= 65; 3. American Society of Anesthesiologists (ASA) classification I-II; 4. 18.5 <= Body Mass Index BMI <= 28.0; 5. The patient agrees to participate in this trial, is willing to comply with the study requirements to complete all visits, and signs an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients who are not suitable for surgery with electrodes attached to the forehead; 2.Patients with a history of using psychotropic drugs or alcohol dependence in the past; 3.Patients who are unable to communicate normally with researchers or complete the informed consent process; 4.Patients with cognitive impairment; 5.Pregnant and lactating women; 6.Patients with severe liver and kidney dysfunction (creatinine and urea nitrogen levels greater than 1.5 times normal); 7.Patients who have participated or are currently participating in other clinical trials within the past month; 8.Researchers believe that there are other situations that are not suitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anesthesia stability;Anesthesiologist workload; | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of time required to maintain appropriate sedation effect;Body movement frequency;Intraoperative awareness of incidence rate;Comparison of sedative (propofol) dosage;Comparison of analgesic drug (remifentanil) dosage;Comparison of the dosage of sedatives (propofol) during induction period;Comparison of the dosage of induction phase analgesics (remifentanil);Heart rate stability;Wake up duration; | — |
Countries
China
Contacts
Public ContactAnshi Wu
Beijing Chao-Yang Hospital, Capital Medical University
Outcome results
None listed